| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 13,067 | 12,733 | 17,289 | 15,725 | | Cost of Revenue | 9,845 | 9,769 | 14,690 | 13,371 | | | Gross Profit | 3,222 | 2,964 | 2,598 | 2,354 | | | Operating Expenses | | Research Development | 1,123 | 1,268 | 846 | 1,024 | | Selling General and Administrative | 3,955 | 3,862 | 3,839 | 4,652 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,856) | (2,165) | (2,086) | (3,323) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 27 | 302 | 351 | 16 | | Earnings Before Interest And Taxes | (1,829) | (1,863) | (1,735) | (3,307) | | Interest Expense | 21 | 29 |
-
|
-
| | Income Before Tax | (1,849) | (1,892) | (1,735) | (3,307) | | Income Tax Expense | 38 | 40 | 38 | (398) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,887) | (1,932) | (1,772) | (2,909) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,887) | (1,932) | (1,772) | (2,909) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,887) | ($1,932) | ($1,772) | ($2,909) |
|
0.51% Nasdaq 
Income Statement
